Ophtesic (Anhydrous Lidocaine Hydrochloride)

Lidocaine blocks voltage‑gated sodium channels on nerve fibers in the ocular surface, preventing the influx of sodium ions required for depolarization. This reversible inhibition stops nerve impulse transmission, resulting in localized loss of sensation without affecting surrounding tissues.

The specific dose and frequency of Ophtesic are determined by the prescribing clinician based on the procedure, patient age, and ocular condition. Healthcare professionals select the appropriate volume and concentration to achieve adequate anesthesia while minimizing exposure.

Safety data for Ophtesic in pregnancy and lactation are limited. It should be used only if clearly needed after a careful risk‑benefit assessment by the prescriber. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their healthcare provider.

To request Ophtesic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will verify trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Ophtesic contains lidocaine, an amide‑type anesthetic known for rapid onset and reliable depth of anesthesia. Compared with ester‑type agents such as proparacaine, lidocaine often provides a slightly longer duration of effect and a well‑established safety profile for short‑term ocular use.

Ophtesic should be stored at controlled room temperature, protected from light and moisture, and kept in its original sealed container. Avoid freezing or exposing the solution to extreme temperatures, and discard any product that appears cloudy or contaminated.

Ophtesic is applied topically to the ocular surface as a sterile drop or small volume instillation. The prescriber directs the patient or clinician on the exact number of drops, timing before the procedure, and any necessary precautions to ensure effective anesthesia.

Serious risks, though rare, include severe allergic reactions such as anaphylaxis, corneal ulceration, persistent corneal edema, and vision loss. Immediate medical attention is required if signs of a severe reaction, such as intense pain, swelling, or sudden visual changes, occur after application.

Ophtesic should not be used by individuals with known hypersensitivity to lidocaine or other amide local anesthetics, patients with active corneal disease or epithelial defects, and those with uncontrolled ocular infections. Contraindications are determined by the prescribing clinician based on the patient’s medical history.